Tm Bioscience to Supply St. Joseph's Hospital with Tag-It™ Reagents
News Feb 16, 2006
"We selected Tm's Tag-It™ platform because we were impressed by its performance and flexibility. Tm's technology has allowed us to develop an assay testing for numerous CF associated mutations at once in a single well, an extremely time-efficient and cost-effective solution," said John Stone, Director of Laboratory Services at St. Joseph's Hospital.
"Because the platform is open and flexible, we ultimately anticipate providing our patients with a broader menu of important genetic tests using Tm reagents."
"We look forward to working with St. Joseph's Hospital to provide leading edge medical laboratory services for the state of Arizona," said Greg Hines, President and CEO of Tm Bioscience.
Unlike most cells in the rest of our body, the DNA (the genome) in each of our brain cells varies from cell to cell, caused by somatic changes. But much remains unknown, including when these changes arise, their size and locations, and whether they are random or regulated. Now, researchers have developed new techniques allowing the detection of CNVs smaller than one million base pairs.